NO2018017I1 - Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC - Google Patents

Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC

Info

Publication number: NO2018017I1
Authority: NO; Norway
Prior art keywords: spc; interleukin; extended; receptor antibody; cell growth
Prior art date: 1994-10-07

Application number

NO2018017C

Other languages

English (en)

Original Assignee

Kishimoto Tadamitsu

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-07

Filing date

2018-05-23

Publication date

2018-05-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17112746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2018017(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-05-23 Application filed by Kishimoto Tadamitsu, Chugai Pharmaceutical Co Ltd filed Critical Kishimoto Tadamitsu

2018-05-23 Publication of NO2018017I1 publication Critical patent/NO2018017I1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO2018017C 1994-10-07 2018-05-23 Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC NO2018017I1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP24403594		1994-10-07
PCT/JP1995/001144 WO1996011020A1 (en)	1994-10-07	1995-06-07	Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient

Publications (1)

Publication Number	Publication Date
NO2018017I1 true NO2018017I1 (no)	2018-05-23

Family

ID=17112746

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
NO19971546A NO321089B1 (no)	1994-10-07	1997-04-04	Anvendelse av et interleukin-6 antistoff eller interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandling av unormal synovialcelle-vekst.
NO20055446A NO20055446L (no)	1994-10-07	2005-11-17	Anvendelse av et interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandlingav kronisk reumatoid artritt
NO2009009C NO2009009I2 (no)	1994-10-07	2009-05-04	Tocilizumab
NO2018017C NO2018017I1 (no)	1994-10-07	2018-05-23	Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
NO19971546A NO321089B1 (no)	1994-10-07	1997-04-04	Anvendelse av et interleukin-6 antistoff eller interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandling av unormal synovialcelle-vekst.
NO20055446A NO20055446L (no)	1994-10-07	2005-11-17	Anvendelse av et interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandlingav kronisk reumatoid artritt
NO2009009C NO2009009I2 (no)	1994-10-07	2009-05-04	Tocilizumab

Country Status (18)

Country	Link
EP (3)	EP2107070A1 (no)
JP (1)	JP3067987B2 (no)
KR (1)	KR100306517B1 (no)
CN (2)	CN101601861A (no)
AT (1)	ATE552012T1 (no)
AU (1)	AU700819B2 (no)
CA (1)	CA2201781C (no)
CZ (1)	CZ296919B6 (no)
DK (1)	DK0783893T3 (no)
ES (1)	ES2384222T3 (no)
FI (1)	FI120721B (no)
HU (1)	HU223602B1 (no)
LU (1)	LU92048I2 (no)
NO (4)	NO321089B1 (no)
PL (1)	PL186506B1 (no)
PT (1)	PT783893E (no)
RU (1)	RU2147443C1 (no)
WO (1)	WO1996011020A1 (no)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998042377A1 (fr)	1997-03-21	1998-10-01	Chugai Seiyaku Kabushiki Kaisha	Substances servant a la prevention ou au traitement de maladies liees a la cellule-t sensibilisee contenant comme principe actif des antagonistes de l'il-6
PT1004315E (pt) *	1997-08-15	2008-07-09	Chugai Pharmaceutical Co Ltd	Profilácticos e/ou medicamentos contendo anticorpos neutralizantes anti-receptor de il-6 para reduzir a excreção de proteínas urinárias no lúpus eritematoso sistémico
US6723319B1 (en)	1998-03-17	2004-04-20	Chugai Seiyaku Kabushiki Kaisha	Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies
CN1188521C (zh)	1998-04-17	2005-02-09	三得利株式会社	编码具有合成噢哢类活性的蛋白质的基因
CA2426679C (en)	2000-10-25	2012-11-20	Chugai Seiyaku Kabushiki Kaisha	Preventive or therapeutic agent for psoriasis comprising il-6 antagonist as active ingredient
JPWO2002066063A1 (ja) *	2001-02-23	2004-06-17	星野　友昭	代謝性骨疾患治療剤
UA80091C2 (en) *	2001-04-02	2007-08-27	Chugai Pharmaceutical Co Ltd	Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
ATE412013T1 (de) *	2001-04-05	2008-11-15	Immuno Biological Lab Co Ltd	Anti-osteopontin-antikörper und dessen verwendung
CN101721362B (zh)	2002-02-14	2018-07-03	中外制药株式会社	包含抗体的溶液制剂
GB2401040A (en)	2003-04-28	2004-11-03	Chugai Pharmaceutical Co Ltd	Method for treating interleukin-6 related diseases
JP2007104901A (ja) *	2004-01-16	2007-04-26	Astellas Pharma Inc	関節リウマチ治療薬のスクリーニング法
CA2555688C (en) *	2004-02-11	2011-11-08	Warner-Lambert Company Llc	Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies
AR048335A1 (es)	2004-03-24	2006-04-19	Chugai Pharmaceutical Co Ltd	Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
RU2293559C2 (ru) *	2005-03-09	2007-02-20	Лидия Николаевна Долгова	Способ подготовки к любрикантной терапии
RU2293560C2 (ru) *	2005-03-09	2007-02-20	Лидия Николаевна Долгова	Способ лечения хронических гонартритов у больных остеоартрозом
WO2006106905A1 (ja)	2005-03-31	2006-10-12	Chugai Seiyaku Kabushiki Kaisha	会合制御によるポリペプチド製造方法
PE20061324A1 (es) *	2005-04-29	2007-01-15	Centocor Inc	Anticuerpos anti-il-6, composiciones, metodos y usos
AU2006298767B2 (en) *	2005-09-28	2013-01-10	Cytos Biotechnology Ag	Interleukin-1 conjugates and uses thereof
RU2446826C2 (ru)	2005-10-14	2012-04-10	Фукуока Юниверсити	Агенты для подавления повреждения трансплантированных островков после трансплантации островков
BRPI0617664B8 (pt)	2005-10-21	2021-05-25	Chugai Pharmaceutical Co Ltd	uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
AR057582A1 (es)	2005-11-15	2007-12-05	Nat Hospital Organization	Agentes para suprimir la induccion de linfocitos t citotoxicos
CN101370521A (zh)	2006-01-27	2009-02-18	学校法人庆应义塾	伴有脉络膜血管生成的疾病的治疗药
WO2007114319A1 (ja)	2006-03-31	2007-10-11	Chugai Seiyaku Kabushiki Kaisha	抗体の血中動態を制御する方法
US9670269B2 (en)	2006-03-31	2017-06-06	Chugai Seiyaku Kabushiki Kaisha	Methods of modifying antibodies for purification of bispecific antibodies
JP5754875B2 (ja)	2006-04-07	2015-07-29	国立大学法人大阪大学	筋再生促進剤
US8080248B2 (en)	2006-06-02	2011-12-20	Regeneron Pharmaceuticals, Inc.	Method of treating rheumatoid arthritis with an IL-6R antibody
AU2007254831B2 (en)	2006-06-02	2012-03-22	Regeneron Pharmaceuticals, Inc.	High affinity antibodies to human IL-6 receptor
EP2064241B1 (en)	2006-08-03	2015-10-07	Vaccinex, Inc.	Anti-il-6 monoclonal antibodies and uses thereof
JP2010095445A (ja) *	2006-12-27	2010-04-30	Tokyo Medical & Dental Univ	Ｉｌ−６アンタゴニストを有効成分とする炎症性筋疾患治療剤
KR101508019B1 (ko)	2007-01-23	2015-04-06	고쿠리츠 다이가쿠 호우징 신슈 다이가쿠	만성 거부반응 억제제
EP3127921A1 (en)	2007-09-26	2017-02-08	Chugai Seiyaku Kabushiki Kaisha	Method of modifying isoelectric point of antibody via amino acid substition in cdr
PE20140132A1 (es)	2007-09-26	2014-02-14	Chugai Pharmaceutical Co Ltd	Anticuerpo anti-receptor de il-6
CN101874041B (zh)	2007-09-26	2013-06-19	中外制药株式会社	抗体恒定区修饰体
TWI548418B (zh)	2007-12-05	2016-09-11	Chugai Pharmaceutical Co Ltd	Anti-NR10 / IL-31RA antibody and its use
EP2708559B1 (en)	2008-04-11	2018-03-28	Chugai Seiyaku Kabushiki Kaisha	Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
US8034344B2 (en)	2008-05-13	2011-10-11	Novimmune S.A.	Anti-IL-6/IL-6R antibodies and methods of use thereof
CN104906581A (zh)	2008-06-05	2015-09-16	国立研究开发法人国立癌症研究中心	神经浸润抑制剂
US8188235B2 (en)	2008-06-18	2012-05-29	Pfizer Inc.	Antibodies to IL-6 and their uses
TWI440469B (zh)	2008-09-26	2014-06-11	Chugai Pharmaceutical Co Ltd	Improved antibody molecules
EP3674317B1 (en)	2009-03-19	2024-12-11	Chugai Seiyaku Kabushiki Kaisha	Antibody constant region variant
WO2010107110A1 (ja)	2009-03-19	2010-09-23	中外製薬株式会社	抗体定常領域改変体
CN102459344A (zh)	2009-05-15	2012-05-16	中外制药株式会社	抗axl抗体
CN102427822A (zh) *	2009-05-18	2012-04-25	香港大学	治疗炎症性关节炎的组合物和方法
US10150808B2 (en)	2009-09-24	2018-12-11	Chugai Seiyaku Kabushiki Kaisha	Modified antibody constant regions
JO3417B1 (ar)	2010-01-08	2019-10-20	Regeneron Pharma	الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
AR080428A1 (es)	2010-01-20	2012-04-11	Chugai Pharmaceutical Co Ltd	Formulaciones liquidas estabilizadas contentivas de anticuerpos
EP2543730B1 (en)	2010-03-04	2018-10-31	Chugai Seiyaku Kabushiki Kaisha	Antibody constant region variant
US20130149302A1 (en)	2010-05-28	2013-06-13	Chugai Seiyaku Kabushiki Kaisha	Therapeutic agents for pancreatic cancer
JP6051049B2 (ja)	2010-05-28	2016-12-21	中外製薬株式会社	抗腫瘍ｔ細胞応答増強剤
EP3351559A3 (en)	2010-11-08	2018-10-31	F. Hoffmann-La Roche AG	Subcutaneously administered anti-il-6 receptor antibody
HRP20180421T1 (hr)	2010-11-17	2018-04-20	Chugai Seiyaku Kabushiki Kaisha	Višestruko specifične molekule za vezanje na antigen koje imaju alternativnu funkciju u odnosu na funkciju faktora viii zgrušavanja krvi
TWI654204B (zh)	2010-11-30	2019-03-21	中外製藥股份有限公司	具有鈣依存性的抗原結合能力之抗體
JP4987117B2 (ja)	2010-12-27	2012-07-25	中外製薬株式会社	Ｉｌ−６アンタゴニストを有効成分として含有する血中ｍｍｐ−３濃度低下剤
WO2012115241A1 (ja)	2011-02-25	2012-08-30	中外製薬株式会社	FcγRIIb特異的Fc抗体
TW201817744A (zh)	2011-09-30	2018-05-16	日商中外製藥股份有限公司	具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
WO2013047748A1 (ja)	2011-09-30	2013-04-04	中外製薬株式会社	複数の生理活性を有する抗原の消失を促進する抗原結合分子
TWI589299B (zh)	2011-10-11	2017-07-01	再生元醫藥公司	用於治療類風濕性關節炎之組成物及其使用方法
US9580501B2 (en)	2011-12-16	2017-02-28	Synthon Biopharmaceuticals B.V.	Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
JP6117915B2 (ja)	2012-05-21	2017-04-19	コリアリサーチインスティテュートオブバイオサイエンスアンドバイオテクノロジーＫｏｒｅａＲｅｓｅａｒｃｈＩｎｓｔｉｔｕｔｅＯｆＢｉｏｓｃｉｅｎｃｅＡｎｄＢｉｏｔｅｃｈｎｏｌｏｇｙ	ミゾコウジュの抽出物またはその分画物を有効成分として含む、ｓｔａｔ３媒介性疾患の予防または治療用医薬組成物
EP3009518B1 (en)	2013-06-11	2020-08-12	National Center of Neurology and Psychiatry	Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy
RU2730594C2 (ru)	2013-09-27	2020-08-24	Чугаи Сейяку Кабусики Кайся	Способ получения полипептидного гетеромультимера
US9017678B1 (en)	2014-07-15	2015-04-28	Kymab Limited	Method of treating rheumatoid arthritis using antibody to IL6R
MA40764A (fr)	2014-09-26	2017-08-01	Chugai Pharmaceutical Co Ltd	Agent thérapeutique induisant une cytotoxicité
CA2963760A1 (en)	2014-12-19	2016-06-23	Yoshinao Ruike	Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
ES2899894T3 (es)	2014-12-19	2022-03-15	Chugai Pharmaceutical Co Ltd	Anticuerpos anti-C5 y métodos de uso
MX2017008978A (es)	2015-02-05	2017-10-25	Chugai Pharmaceutical Co Ltd	Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, antiocuerpor de union a interleucina 8 (il-8) y usos de los mismos.
ES2967627T3 (es)	2015-02-27	2024-05-03	Chugai Pharmaceutical Co Ltd	Composición para tratar enfermedades relacionadas con IL-6
WO2016159213A1 (ja)	2015-04-01	2016-10-06	中外製薬株式会社	ポリペプチド異種多量体の製造方法
ES2888801T3 (es)	2015-05-19	2022-01-07	Nat Center Neurology & Psychiatry	Método para determinar la aplicación de una terapia nueva en pacientes con esclerosis múltiple (EM)
WO2016195088A1 (ja)	2015-06-04	2016-12-08	国立研究開発法人国立精神・神経医療研究センター	Ｉｌ－６阻害剤を有効成分とする精神疾患治療剤
CN108473583A (zh)	2015-11-03	2018-08-31	赛诺菲生物技术公司	用于治疗葡萄膜炎和黄斑水肿的包含il6r抗体的组合物及其使用方法
WO2017110981A1 (en)	2015-12-25	2017-06-29	Chugai Seiyaku Kabushiki Kaisha	Anti-myostatin antibodies and methods of use
SG11201803989WA (en)	2015-12-28	2018-06-28	Chugai Pharmaceutical Co Ltd	Method for promoting efficiency of purification of fc region-containing polypeptide
AU2017233658B2 (en)	2016-03-14	2023-09-21	Chugai Seiyaku Kabushiki Kaisha	Cell injury inducing therapeutic drug for use in cancer therapy
MA44780A (fr)	2016-04-28	2019-03-06	Chugai Pharmaceutical Co Ltd	Préparation contenant un anticorps
TWI831965B (zh)	2016-08-05	2024-02-11	日商中外製藥股份有限公司	Il-8相關疾病之治療用或預防用組成物
CN108339118A (zh) *	2017-01-23	2018-07-31	瑞阳(苏州)生物科技有限公司	治疗或预防阻塞性睡眠呼吸暂停的药物组合物
EP3620531A4 (en)	2017-05-02	2021-03-17	National Center of Neurology and Psychiatry	METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS
RU2020111737A (ru)	2017-09-13	2021-10-13	Цзянсу Хэнжуй Медицин Ко., Лтд.	Антитело против il-6r и его антигенсвязывающий фрагмент и медицинское применение
WO2019078344A1 (ja)	2017-10-20	2019-04-25	学校法人兵庫医科大学	抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物
MA50534A (fr)	2017-11-01	2020-09-09	Chugai Pharmaceutical Co Ltd	Variant d'anticorps et isoforme à activité biologique réduite
MX2021002422A (es)	2018-08-29	2021-07-15	Regeneron Pharma	Métodos y composiciones para el tratamiento de sujetos que padecen artritis reumatoide.
CN109517064B (zh) *	2018-10-10	2020-05-08	北京汇智和源生物技术有限公司	白介素-6的人源化单克隆抗体、其编码基因及应用
TW202521583A (zh)	2019-01-31	2025-06-01	法商賽諾菲生物技術公司	用於治療幼年原發性關節炎之組成物及方法
WO2020178193A1 (en)	2019-03-01	2020-09-10	INSERM (Institut National de la Santé et de la Recherche Médicale)	Method of treatment of sarcoidosis
CA3137909A1 (en)	2019-04-24	2020-10-29	Sanofi Biotechnology	Methods of diagnosis and treatment of rheumatoid arthritis
US12297279B2 (en)	2019-06-04	2025-05-13	Sanofi Biotechnology	Compositions and methods for treating pain in subjects with rheumatoid arthritis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5171840A (en)	1988-01-22	1992-12-15	Tadamitsu Kishimoto	Receptor protein for human B cell stimulatory factor-2
EP0399429A1 (en) *	1989-05-22	1990-11-28	Toray Industries, Inc.	Anti-human interleukin-6 monoclonal antibody
ATE144713T1 (de) *	1989-07-20	1996-11-15	Tadamitsu Kishimoto	Antikörper gegen menschlichen interleukin-6- rezeptor
JP2898064B2 (ja)	1989-08-03	1999-05-31	忠三岸本	ヒトｇｐ１３０蛋白質
DE3939706C1 (no) *	1989-12-01	1991-03-21	Centre Regional De Transfusion Sanguine, Besancon, Fr
CA2070424A1 (en) *	1989-12-04	1991-06-05	H. Fletcher Starnes	Method of treating septic shock
JP2898040B2 (ja)	1990-01-26	1999-05-31	忠三岸本	ｇｐ１３０蛋白質に対する抗体
US5210075A (en)	1990-02-16	1993-05-11	Tanabe Seiyaku Co., Ltd.	Interleukin 6 antagonist peptides
JPH0489433A (ja)	1990-07-27	1992-03-23	Hitachi Chem Co Ltd	免疫調節剤
JP2947924B2 (ja) *	1990-11-21	1999-09-13	信和化工株式会社	光学異性体用分離剤
JPH04187645A (ja) *	1990-11-22	1992-07-06	Chuzo Kishimoto	インターロイキン―６作用抑制剤
AU668349B2 (en) *	1991-04-25	1996-05-02	Chugai Seiyaku Kabushiki Kaisha	Reconstituted human antibody against human interleukin 6 receptor
JPH05300338A (ja)	1992-04-17	1993-11-12	Ricoh Co Ltd	複合機
JPH05304986A (ja) *	1992-04-28	1993-11-19	Tosoh Corp	ｇｐ１３０蛋白質に対するモノクロ−ナル抗体
FR2694767B1 (fr) *	1992-08-13	1994-10-21	Innotherapie Lab Sa	Anticorps monoclonaux anti-IL6R, et leurs applications.
JPH06134617A (ja)	1992-10-23	1994-05-17	Amada Co Ltd	鋸盤の鋸刃テンション自動調整装置
JP3525221B2 (ja) *	1993-02-17	2004-05-10	味の素株式会社	免疫抑制剤

1995
- 1995-06-07 PL PL95319574A patent/PL186506B1/pl unknown
- 1995-06-07 CA CA002201781A patent/CA2201781C/en not_active Expired - Lifetime
- 1995-06-07 HU HU9701906A patent/HU223602B1/hu active Protection Beyond IP Right Term
- 1995-06-07 WO PCT/JP1995/001144 patent/WO1996011020A1/ja not_active Ceased
- 1995-06-07 ES ES95921130T patent/ES2384222T3/es not_active Expired - Lifetime
- 1995-06-07 AT AT95921130T patent/ATE552012T1/de active
- 1995-06-07 EP EP09009350A patent/EP2107070A1/en not_active Withdrawn
- 1995-06-07 CN CNA2009101322726A patent/CN101601861A/zh active Pending
- 1995-06-07 PT PT95921130T patent/PT783893E/pt unknown
- 1995-06-07 EP EP09000787A patent/EP2077120A3/en not_active Withdrawn
- 1995-06-07 KR KR1019970702209A patent/KR100306517B1/ko not_active Expired - Lifetime
- 1995-06-07 RU RU97108276A patent/RU2147443C1/ru active Protection Beyond IP Right Term
- 1995-06-07 DK DK95921130.1T patent/DK0783893T3/da active
- 1995-06-07 CN CN2008102100070A patent/CN101361972B/zh not_active Expired - Lifetime
- 1995-06-07 AU AU26303/95A patent/AU700819B2/en not_active Expired
- 1995-06-07 CZ CZ0103497A patent/CZ296919B6/cs not_active IP Right Cessation
- 1995-06-07 EP EP95921130A patent/EP0783893B1/en not_active Expired - Lifetime
- 1995-10-06 JP JP7284364A patent/JP3067987B2/ja not_active Expired - Lifetime
1997
- 1997-04-04 FI FI971404A patent/FI120721B/fi not_active IP Right Cessation
- 1997-04-04 NO NO19971546A patent/NO321089B1/no not_active IP Right Cessation
2005
- 2005-11-17 NO NO20055446A patent/NO20055446L/no not_active Application Discontinuation
2009
- 2009-05-04 NO NO2009009C patent/NO2009009I2/no unknown
2012
- 2012-07-20 LU LU92048C patent/LU92048I2/fr unknown
2018
- 2018-05-23 NO NO2018017C patent/NO2018017I1/no unknown

Also Published As

Publication number	Publication date
HK1127497A1 (en)	2009-09-25
WO1996011020A1 (en)	1996-04-18
CZ296919B6 (cs)	2006-07-12
NO20055446L (no)	1997-06-04
EP0783893B1 (en)	2012-04-04
NO2009009I1 (no)	2009-05-11
NO971546D0 (no)	1997-04-04
LU92048I2 (fr)	2012-09-20
HUT77036A (hu)	1998-03-02
RU2147443C1 (ru)	2000-04-20
NO321089B1 (no)	2006-03-13
AU2630395A (en)	1996-05-02
FI120721B (fi)	2010-02-15
HU223602B1 (hu)	2004-10-28
CA2201781C (en)	2010-01-12
NO2009009I2 (no)	2013-03-18
PT783893E (pt)	2012-05-24
CA2201781A1 (en)	1996-04-18
EP0783893A4 (en)	1998-04-22
FI971404A0 (fi)	1997-04-04
DK0783893T3 (da)	2012-05-29
PL186506B1 (pl)	2004-01-30
EP2107070A1 (en)	2009-10-07
CN101361972B (zh)	2011-05-25
EP2077120A2 (en)	2009-07-08
EP0783893A1 (en)	1997-07-16
FI971404L (fi)	1997-06-03
NO971546L (no)	1997-06-04
JPH08208514A (ja)	1996-08-13
AU700819B2 (en)	1999-01-14
CN101601861A (zh)	2009-12-16
CZ103497A3 (en)	1997-08-13
JP3067987B2 (ja)	2000-07-24
ATE552012T1 (de)	2012-04-15
CN101361972A (zh)	2009-02-11
ES2384222T3 (es)	2012-07-02
KR100306517B1 (ko)	2001-11-30
PL319574A1 (en)	1997-08-18
EP2077120A3 (en)	2009-07-15

Publication	Publication Date	Title
NO2018017I1 (no)	2018-05-23	Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC
DK0601386T3 (da)	2003-05-26	Sulfonamider
RU97108276A (ru)	1999-05-20	Лечебные средства против хронического ревматоидного артрита, содержащие антагонист il-6 в качестве эффективного компонента
AU6202396A (en)	1996-10-31	Pegylation of polypeptides
GR1000130B (el)	1991-07-31	Διαταξη για την επεξεργασια σπορων.
DE68903485D1 (de)	1992-12-17	Einstellbare distanzschraube.
FR2689188B1 (fr)	1995-08-11	Dispositif s'opposant aux rajustements pour une vis de reglage.
FR2566084B1 (fr)	1990-03-23	Dispositif d'avance utilisant une vis a billes
EP0698023A4 (en)	1997-07-02	FIBRINOGEN RECEPTOR ANTAGONISTS
DE69426452D1 (de)	2001-01-25	Fibrinogen receptor antagonisten
ES8801912A1 (es)	1987-08-01	Procedimiento para la obtencion de benzopiranos sustituidos.
FR2614223B1 (fr)	1990-08-24	Dispositif d'usinage par etincelage controlant la precision de l'usinage.
DE59102535D1 (de)	1994-09-22	Schraube zum Befestigen von Gipskartonplatten.
IT8522306A0 (it)	1985-09-30	Apparato per il riflusso di gas di scarico.
ATE160307T1 (de)	1997-12-15	Verschraubungsgerät
DK435089A (da)	1990-03-03	Anvendelse af zofenopril til behandling af rheumatoid arthritis
DE69202465D1 (de)	1995-06-22	Ventilkaskaden für hohe Spannungen.
ATA325687A (de)	1989-10-15	Abgasfuehrung fuer zumindest zwei einander benachbart angeordnete brennerbeheizte geraete
FR2562303B1 (fr)	1986-07-04	Table d'harmonie perfectionnee pour piano droit
KR850004263U (ko)	1985-07-22	보습볏의 경사각도 조절장치